$0.13 EPS Expected for Vitamin Shoppe Inc (VSI)

October 7, 2017 - By Richard Conner

Analysts await Vitamin Shoppe Inc (NYSE:VSI) to report earnings on November, 1. They expect $0.13 EPS, down 74.00 % or $0.37 from last year’s $0.5 per share. VSI’s profit will be $3.06 million for 10.19 P/E if the $0.13 EPS becomes a reality. After $0.23 actual EPS reported by Vitamin Shoppe Inc for the previous quarter, Wall Street now forecasts -43.48 % negative EPS growth. The stock decreased 0.93% or $0.05 on October 6, reaching $5.3. About 579,037 shares traded. Vitamin Shoppe Inc (NYSE:VSI) has declined 57.70% since October 8, 2016 and is downtrending. It has underperformed by 74.40% the S&P500.

Vitamin Shoppe Inc (NYSE:VSI) Ratings Coverage

Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe had 24 analyst reports since August 6, 2015 according to SRatingsIntel. As per Tuesday, January 17, the company rating was downgraded by Morgan Stanley. JP Morgan downgraded the stock to “Neutral” rating in Thursday, October 27 report. The firm has “Hold” rating given on Thursday, May 11 by Gabelli. The stock has “Hold” rating by Deutsche Bank on Thursday, August 6. The rating was upgraded by Zacks to “Sell” on Saturday, August 8. Barclays Capital initiated Vitamin Shoppe Inc (NYSE:VSI) on Friday, September 23 with “Equal Weight” rating. Robert W. Baird maintained Vitamin Shoppe Inc (NYSE:VSI) rating on Friday, September 15. Robert W. Baird has “Hold” rating and $7.0 target. Morgan Stanley maintained Vitamin Shoppe Inc (NYSE:VSI) rating on Monday, October 2. Morgan Stanley has “Equal-Weight” rating and $7.5 target. The firm has “Hold” rating given on Thursday, November 5 by Deutsche Bank. Deutsche Bank maintained Vitamin Shoppe Inc (NYSE:VSI) rating on Thursday, August 10. Deutsche Bank has “Hold” rating and $7 target.

Vitamin Shoppe, Inc. is a multi-channel specialty retailer and contract maker of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The company has market cap of $124.91 million. The Firm operates through three divisions: retail, direct and manufacturing. It currently has negative earnings. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

More notable recent Vitamin Shoppe Inc (NYSE:VSI) news were published by: Seekingalpha.com which released: “Vitamin Shoppe: Is Now The Time To Buy?” on August 10, 2017, also Prnewswire.com with their article: “VITAMIN SHOPPE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN …” published on September 23, 2017, Prnewswire.com published: “Vitamin Shoppe, Inc. Announces Entrance into China” on October 02, 2017. More interesting news about Vitamin Shoppe Inc (NYSE:VSI) were released by: Seekingalpha.com and their article: “Will Vitamin Shoppe Make It?” published on September 04, 2017 as well as Prnewswire.com‘s news article titled: “VITAMIN SHOPPE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who …” with publication date: September 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com